Curie Oncology

04/02/2026

26/01/2026

These coordinators will likely begin their work by the middle of the year. Read more at straitstimes.com. Read more at straitstimes.com.

26/01/2026

20/01/2026

Dr Yvonne was invited to take part in a virtual and in-person session with haematologists from 108 Military Hospital, Blood Transfusion and Haematology Hospital, and Bach Mai Hospital:
CAR-T Therapy in R/R DLBCL – Update on RWE and Treatment Journey. 💉🩺

The session was lively and well attended by haematologists from both Hanoi and Ho Chi Minh City, and concluded with an engaging Q&A that lasted almost an hour. It is always a pleasure to connect with colleagues from Vietnam and learn from one another. 🌏🤝

05/01/2026

We are proud to share that Dr. Choo Su Pin was invited as a speaker at a China online symposium dedicated to precision treatment for gastric cancer.

The symposium brought together leading oncology experts from China to discuss the latest clinical advances, treatment strategies, and real-world experiences in gastric cancer management with Dr Choo and Prof Kei Muro from Japan. During her session, Dr. Choo shared her clinical experiences and offered practical insights from multinational treatment settings and demonstrating how precision medicine can improve patient outcomes.

Her presentation contributed to rich discussions with fellow experts, highlighting innovative strategies in targeted therapy, and multidisciplinary care. The event attracted strong engagement from the medical community, reaching a total viewership of 12,000 across two major Chinese platforms, underscoring the global interest in advanced gastric cancer treatment and the value of international academic collaboration.

30/12/2025

Day 3 of ESMO Asia featured the Progress and Potential in Targeting RAS in Cancer session, where Dr. Choo presented on RAS Targeting Strategies in GI Cancer, sharing updates on emerging therapies and precision approaches. She was joined by Dr. Shubham Pant, Dr. Daniel Tan, and Dr. Stephen Chan, who offered complementary perspectives on advances in RAS-driven cancers. Definitely a ln unmet need in oncology🔬✨

The session underscored how fast the field is evolving—and the exciting potential these breakthroughs hold for improving patient outcomes.

27/12/2025

Day 2 of ESMO Asia featured a session chaired by Dr. Choo, with Florian Lordick (Leipzig, DE) sharing the latest insights from the ESMO Gastrointestinal Oncology Journal. The discussion focused on CLDN18.2 as a new biomarker in the treatment of gastric cancers. The setting allowed for an interactive session with many questions from the audience. 🌟🔬

25/12/2025

Wishing you a Merry Christmas and a Happy New Year 🎄✨
May the season bring you health, happiness, and warmth.

24/12/2025

On ESMO Asia Day 1, Dr Joline had the privilege of chairing the ESMO satellite symposium on navigating treatment for HR+ HER2- metastatic breast cancer🎗️. The rapid expansion of biomarker-driven therapeutic options in recent years has been remarkable, and learning from our APAC colleagues in Australia and Taiwan about best practices for testing and treatment sequencing was truly inspiring🌏💡.

Dr Choo also had the honor of chairing and moderating this year’s ESMO Women for Oncology (W4O) Forum alongside Dr Janice Tsang from Hong Kong👩‍⚕️👩‍⚕️. They were joined by inspiring colleagues from Spain, New Zealand, Bangladesh, and Singapore for a meaningful discussion on supporting women in oncology to build equitable, fulfilling, and successful careers💪✨. The panel’s personal anecdotes—honest, vulnerable, and powerful—resonated deeply with the room❤️. Their voices reminded us why this work matters and why the mission of W4O continues to be so important. It was truly heartening to see young female oncologists step forward, speak up, and ask thoughtful questions👏. More information on the ESMO W4O committee’s mission can be found here: https://www.esmo.org/career-development/women-for-oncology

Curie also had the honor of being involved in two studies selected for poster presentations📄🔬: one led by Dr Choo on functional drug sensitivity testing in refractory GI cancers, and another on the real-world use of zolbetuximab in gastric cancers in collaboration with NCCS.

21/12/2025

ESMO Asia Symposium – Insight to Impact in Advanced Breast Cancer. Biomarkers driven therapeutic strategy has become the standard of care for hormone receptor positive metastatic breast cancer. In this symposium, Dr. Joline shared insights on therapeutic strategies for metastatic breast cancer post CDK4/6 inhibitor therapy, and discussed how genomic profiling is guiding treatment choices today, helping clinicians provide more personalized and effective care for patients. 🔬💡

18/12/2025

At the Firebird Biologics launch event, Transforming Oncology Care: From Molecular Insights to Patient Wellbeing, Dr. John Chia and Prof. Ho Gwo Fuang shared how Caris molecular profiling is transforming care in endometrial cancer 🔬✨. Dr. Joline Lim highlighted the importance of supportive cancer care, including the benefits of scalp cooling therapy to help combat chemotherapy induced hair loss ❄️💇‍♀️. Patient Sandy’s heartfelt story of her cancer journey reminded us that patients are always at the heart of everything we do ❤️.

The event united leading oncologists and specialists to explore the latest in precision medicine and patient-centered care, sparking meaningful discussions on how molecular insights can enhance outcomes and overall wellbeing.

02/12/2025

On 15 November in Surabaya, Dr. Choo shared the latest updates on Advanced HCC and Advanced Colon Cancer treatments, providing valuable insights into current treatment strategies and developments.

Oncology colleagues from Greater Surabaya presented real-life cases, sparking rich multidisciplinary discussions and collaboration among both onsite and online participants.

It was a meaningful session that strengthened our shared commitment to advancing cancer care. 💡🤝